Boehringer Ingelheim has demonstrated that vaccinating pigs with its FLEXcombo® vaccine, which controls Porcine Circovirus Type 2 (PCV2) and Mycoplasma hyopneumoniae (Mhp) not only improves pig ...

Boehringer Ingelheim’s long-awaited phase 3 lung disease data received a muted reception from analysts who labeled ...

Ingelheim, Germany, 22 May 2025 – Boehringer Ingelheim today announced that new clinical data from two early-stage trials targeting the signal regulatory protein α (SIRPα) innate immune ...

INGELHEIM, Germany, April 2 (Reuters) - Germany's largest pharmaceutical company Boehringer Ingelheim on Wednesday reported a currency-adjusted 6.1% gain in 2024 revenues, buoyed by diabetes drug ...

The Philippine Society of Nephrology (PSN) awarded Boehringer Ingelheim (Philippines), Inc. the prestigious Presidential Service Award during the Annual Convention Opening Ceremony on April 24, 2025, ...

RIDGEFIELD, Conn., May 22, 2025 /PRNewswire/ --Boehringer Ingelheim will present the latest data in its robust oncology pipeline at the 2025 American Society of Clinical Oncology (ASCO ...

Ingelheim, Germany, May 6, 2025 – Boehringer Ingelheim today announces the start of the JADE Phase II clinical study (NCT06769048), investigating the efficacy and safety of BI 1584862 as a ...

The Philippine Society of Nephrology (PSN) awarded Boehringer Ingelheim (Philippines) Inc. the prestigious Presidential ...

Brian Hilberdink, a pharmaceutical industry veteran, recently assumed the role of President, U.S. Human Pharma, at Boehringer Ingelheim. Hilberdink recently sat down for an informal Q&A on his new ...